CD79A and Cowden disease: The most recent guidelines maintain its recommendation of non‐biopsy CD diagnosis to include anti‐tissue transglutaminase IgA antibody (TTG‐IgA) 10× upper limit of normal (ULN) and a positive endomysial IgA antibody (EMA) in a second serum sample.